Be Familiar With Meds for Pediatric Type 2 Diabetes

September 2023

Empagliflozin (Jardiance), now FDA-approved in kids 10 and older, will transform pediatric type 2 diabetes treatment.

Pediatric type 2 diabetes is more aggressive than in adults...complications (kidney disease, etc) develop earlier. So expect meds to be started alongside lifestyle changes.

Med options for children are limited...approval of an SGLT2 inhibitor puts a new class of meds in our toolbox.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Influenza Know What’s New for 2023-2024 Flu Immunizations
Vaccines Help Patients Age 60 and Over Decide About the RSV Vaccine
Depression Be Ready to Manage Treatment-Resistant Depression
Diabetes Know How Bexagliflozin Stacks Up to Other SGLT2 Inhibitors
Dermatology Sort Through Options for Fungal Skin Infections
Pediatrics Be Familiar With Meds for Pediatric Type 2 Diabetes
Psychiatry Put Antipsychotics for Agitation in Dementia in Perspective
NatMed Spotlight Clarify the Effectiveness and Safety of Melatonin

Be Familiar With Meds for Pediatric Type 2 Diabetes

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents